Holen Sie sich die Stockscreener-App
5.68
14.29%
0.71
Handel nachbörslich:
5.59
-0.09
-1.58%
Schlusskurs vom Vortag:
$4.97
Offen:
$5.28
24-Stunden-Volumen:
1.04M
Relative Volume:
1.11
Marktkapitalisierung:
$103.11M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-2.058
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
+12.48%
1M Leistung:
+69.05%
6M Leistung:
-69.35%
1J Leistung:
-55.23%
1-Tages-Spanne:
$5.05
$5.94
1-Wochen-Bereich:
$4.91
$5.94
52-Wochen-Spanne:
$3.10
$21.98
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
5.68 | 90.22M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical wins FDA nod for next-gen Tablo hemodialysis system - MassDevice
Outset Medical, Inc. Announces 510(K) Clearance by the U.S. Food and Drug Administration of Its Next-Generation Tablo Platform - marketscreener.com
Outset Medical Secures FDA Clearance For Next-Generation Tablo Hemodialysis System - Nasdaq
Outset Medical (OM) Gains FDA Clearance for Advanced Tablo Platf - GuruFocus
Outset Medical’s Tablo dialysis system meets FDA cybersecurity standards - Investing.com
Outset Medical Wins FDA Clearance for Next-Gen Tablo System - TipRanks
Outset Medical stock jumps after FDA clears next-gen Tablo platform By Investing.com - Investing.com Nigeria
Outset Medical stock jumps after FDA clears next-gen Tablo platform - Investing.com
Outset Medical, Inc. Announces FDA Clearance for Next-Gen Tablo Platform - TradingView
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned - The Manila Times
Outset Medical receives FDA clearance for next-generation Tablo dialysis system - StreetInsider
Outset Medical, Inc. to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 11, 2026 - Quiver Quantitative
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 - The Manila Times
Dialysis device maker Outset Medical sets Feb. 11 results call - Stock Titan
Will Outset Medical Inc benefit from geopolitical trends2025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Earnings Beat: Is Outset Medical Inc stock risky to hold now2025 Price Momentum & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Don't Ignore The Insider Selling In Outset Medical - Sahm
Aug Levels: Will Outset Medical Inc face regulatory challenges2025 Technical Patterns & Weekly Stock Performance Updates - baoquankhu1.vn
Outset Medical chair and CEO Trigg sells $71k in stock - Investing.com UK
Outset Medical chair and CEO Trigg sells $71k in stock By Investing.com - Investing.com India
Outset Medical (NASDAQ:OM) EVP Marc Nash Sells 5,375 Shares - MarketBeat
Outset Medical (NASDAQ:OM) General Counsel Sells $47,687.68 in Stock - MarketBeat
Leslie Trigg Sells 2,120 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Insider Selling: Outset Medical (NASDAQ:OM) CEO Sells 11,794 Shares of Stock - MarketBeat
Will Outset Medical Inc. benefit from geopolitical trendsQuarterly Trade Summary & AI Enhanced Execution Alerts - bollywoodhelpline.com
Aug Opening: What is Outset Medical Incs 5 year growth outlookWall Street Watch & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Outset Medical (OM) soars 22.2%: Is further upside left in the stock? - MSN
Published on: 2026-01-14 00:30:41 - Bộ Nội Vụ
San Jose-based Outset Medical revenue up 5% to USD 119.5M in FY 2025 - Medical Buyer
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? - Yahoo Finance
Outset Medical reports 5% revenue growth in 2025, names new director - Investing.com Nigeria
Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance By Investing.com - Investing.com South Africa
Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance - Investing.com Australia
Outset Medical Gears Up for J.P. Morgan Healthcare Conference Buckle Up for Exciting Updates! - StocksToTrade
Stifel on Outset Medical Inc. (OM): 'Overall Solid 2025 Finish As Preliminary 4Q25 Sales Beat Consensus' - StreetInsider
Outset Medical reports 5% revenue growth in 2025, names new director By Investing.com - Investing.com South Africa
Outset Medical (OM) Poised for Growth with New Innovations - GuruFocus
Outset Medical Jumps As FY2025 Revenue Rebounds After Prior-Year Decline - Nasdaq
Outset Medical Shines with Dialysis Tech at JP Morgan Healthcare Conference - timothysykes.com
Outset Medical Previews 2025 Results and Adds Director - TipRanks
Outset Medical posts 5% revenue growth, adds board member - StreetInsider
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results - marketscreener.com
Star TribuneOutset Medical Reports Unaudited Fourth Quarter and 2025 Results - FinancialContent
Will Outset Medical Inc. stock see insider buyingJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - ulpravda.ru
Outset Medical (NASDAQ:OM) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
How Outset Medical Inc. stock compares to market leadersModel Comparison & stability guidance for smoother miles - Улправда
Nash, evp, sells Outset Medical (OM) shares worth $461 By Investing.com - Investing.com India
Is Outset Medical Inc. stock cheap compared to fundamentals2025 Biggest Moves & Low Drawdown Trading Techniques - Улправда
Outset Medical general counsel Brottem sells $956 in stock By Investing.com - Investing.com South Africa
Outset Medical general counsel Brottem sells $956 in stock - Investing.com
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):